Autoimmune Life Blog

Eddie James, PhD, earned a new grant to explore early cell changes that lead to T1D, using a new tool pioneered at BRI.

Each summer, BRI welcomes undergraduate interns across our labs. Interns come from universities across the country to get hands-on research experience, learn new tools and techniques and explore careers in biomedical research.

Learn how lab-grown human beta cells are helping Eddie James, PhD, and other BRI researchers answer important questions in type 1 diabetes. 

Dr. Smithmyer is a staff scientist at Benaroya Research Institute (BRI) in the Center for Interventional Immunology. She has kindly agreed to speak with us about what the BRIDge Biorepository is and its importance to the work that scientists like her do in the realm of type 1 diabetes.

BRI investigators Eddie James, PhD, and Caroline Stefani, PhD, are teaming up to take a unique approach to type 1 diabetes research.

Learn about one of the first projects launched with this funding, where Eddie James, PhD, and Caroline Stephanie, PhD, are exploring a new approach to treat type 1 diabetes.

Learn how Eddie James, PhD, Peter Morawski, PhD, and other BRI scientists are exploring tissue-specific immunology and why this approach is fueling discoveries.

BRI researchers are working to develop a groundbreaking new approach to treat type 1 diabetes (T1D). They aim to turn T cells that cause T1D into regulatory T cells (Tregs) that protect you from T1D.

The first symptoms Linda Sloate experienced were aching hands and pain that shot up her arms. She had carpal tunnel surgery in both hands. Then she felt pain in her feet while she was teaching kindergarten and running around after her three children.

James Lord, MD, PhD, has a simple way of explaining the immune system. “It’s not a homogenous pot of stew,” he says. “It’s a carefully orchestrated dance, and doing the right thing at the right time is critical. But it’s very hard to predict the choreography.”